How many mrna therapeutics drugs are tracked?

Drug Landscape tracks 1 mrna therapeutics (1 marketed, 0 Phase 3, 0 Phase 2, 0 Phase 1).

How fresh is this page?

Refreshed every 30 minutes from primary sources (Drugs@FDA, EMA EPAR, ClinicalTrials.gov, sponsor 8-K filings).

mRNA Therapeutics — Pipeline, Approvals, Sponsors

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

mRNA-based therapeutics, primarily delivered via lipid nanoparticles (LNP). Validated platform from COVID vaccines (Moderna, Pfizer/BioNTech). Pipeline expanding into oncology vaccines, rare disease, autoimmune.

Marketed

Filed

Phase 3

Phase 2

Phase 1

Total

Marketed leaders

2021-08-23 — Comirnaty · Pfizer Inc. · vaccine · Infectious Disease

Recent approvals (last 30 days)

No approvals in the last 30 days.

Upcoming PDUFA (next 180 days)

No upcoming PDUFA in next 180 days.

Top sponsors in this modality

Pfizer Inc. · 1 mrna therapeutics

Drug classes within mRNA Therapeutics

vaccine · 1

Subscribe to ongoing alerts

Push every new mrna therapeutics event into your RSS reader:

Other modalities

Biologics Monoclonal Antibodies Small Molecules Antibody-Drug Conjugates Cell Therapies Gene Therapies Gene Editing siRNA Therapeutics Antisense Oligonucleotides Bispecific Antibodies Vaccines

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing